Overview

GL701 (Prestara™) in Women With Systemic Lupus Erythematosus Receiving Treatment With Glucocorticoids

Status:
Completed
Trial end date:
2005-08-01
Target enrollment:
Participant gender:
Summary
Open label safety and efficacy follow-up.
Phase:
Phase 3
Details
Lead Sponsor:
Genelabs Technologies
Treatments:
Dehydroepiandrosterone
Glucocorticoids